This inventor holds 1 USPTO granted patent. Top assignee: Allakos Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Kenneth Luehrsen
Introduction
Kenneth Luehrsen is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of cancer treatment through his innovative work on anti-Siglec-7 antibodies. His research focuses on developing methods and compositions that utilize these antibodies to combat cancer effectively.
Latest Patents
Kenneth Luehrsen holds 1 patent for his invention titled "Anti-Siglec-7 antibodies for the treatment of cancer." This patent outlines the methods and compositions that leverage anti-Siglec-7 antibodies to provide therapeutic benefits in cancer treatment.
Career Highlights
Luehrsen is currently associated with Allakos Inc., a company dedicated to advancing treatments for various diseases. His work at Allakos Inc. reflects his commitment to improving patient outcomes through innovative therapeutic solutions.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Christopher Robert Bebbington and Wouter Korver. These collaborations have further enriched his research and contributed to the development of groundbreaking treatments.
Conclusion
Kenneth Luehrsen's contributions to cancer treatment through his patented inventions highlight his role as an influential inventor in the medical field. His dedication to innovation continues to pave the way for advancements in therapeutic approaches to cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile